Tuesday, June 25, 2019

Medical News | Medical Articles: Using Blue Light to Decrease Blood Pressure

Medical News | Medical Articles

News-Medical

 
 June 25, 2019 
 Hematology 
 The latest hematology news from News Medical 
 #ALT#Using Blue Light to Decrease Blood Pressure

Light is believed to play a vital role in humans’ circadian system. It regulates the circadian system by interacting with the eye’s light-sensitive cells, which, in turn, signal the brain’s body clock.

Find Out More
 
   More screening and new treatments needed for sickle cell diseaseMore screening and new treatments needed for sickle cell disease
 
The promise of new treatments for sickle cell disease, a group of inherited red blood cell disorders, has never been so great, but it will only be realized if there is constant investment in health policies such as programs for screening newborns, especially in sub-Saharan Africa, where most cases occur.
 
   Receiving blood transfusion during liver cancer surgery has higher risk of recurrence and deathReceiving blood transfusion during liver cancer surgery has higher risk of recurrence and death
 
Receiving a blood transfusion during curative surgery for the most common type of liver cancer is associated with a much higher risk of cancer recurrence and dying prematurely, according to new research being presented at this year's Euroanaesthesia congress in Vienna, Austria
 
 Scientists turn type A blood into universal type O, potentially doubling blood transfusion stocks
 
Scientists turn type A blood into universal type O, potentially doubling blood transfusion stocksResearchers have developed a technique for turning type A blood into universal type O blood. The development could boost blood stocks dramatically. So far, the researches have only achieved this using petri dishes in a lab and a lot more research would be needed before the technique could benefit patients in hospitals. However, potentially, the development could be revolutionary in terms of increasing the supply of blood for life-saving transfusions.
 
 
 NHS to roll-out new test for potentially lethal pre-eclampsia
 
NHS to roll-out new test for potentially lethal pre-eclampsiaNHS England will be rolling out a new blood test for pregnant women to check for pre-eclampsia, a common and potentially life-threatening condition.
 
 
 A1c blood test found to be unreliable in diabetes diagnoses
 
A1c blood test found to be unreliable in diabetes diagnosesResearch has found that many cases of diabetes are missed when the hemoglobin A1c blood test is used solely to diagnose the disease. Statistics published by Diabetes UK state that more than five million people in the UK will be living with diabetes by 2025, and in the last 20 years, the number of people diagnosed with diabetes has more than doubled.
 
 
 Research into structure of anticoagulant protein may open new avenues for treatment of thrombosis
 
Research into structure of anticoagulant protein may open new avenues for treatment of thrombosisA collaboration between researchers from Brazil and the United States may open new avenues for the treatment of thrombosis, the leading cause of death among cancer patients.
 
 
 Combination treatment effective as front-line therapy for select chronic lymphocytic leukemia patients
 
Combination treatment effective as front-line therapy for select chronic lymphocytic leukemia patientsIbrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia, have been shown to be effective when given together for high-risk and older patients with the disease, according to a study at The University of Texas MD Anderson Cancer Center.
 
 
 Researchers map bone-marrow microenvironment to shed new light on leukemia
 
Researchers map bone-marrow microenvironment to shed new light on leukemiaStem cells are surrounded and protected by the stem-cell niche - the microenvironment - of the tissue in which they are found.
 
 
 Blood stem cell breakthrough could spare some patients from side effects of cancer treatments
 
Blood stem cell breakthrough could spare some patients from side effects of cancer treatmentsA method of growing blood stem cells in the laboratory has been developed by researchers at Stanford University and the University of Tokyo, in a breakthrough that could spare some people with blood and immune disorders from the side effects of intensive chemotherapy and radiotherapy.
 

No comments:

Post a Comment